This thing could take a while to grow as pilot studies get completed and slow revenue growth..
but looks like it could be an absolute steal if it goes any lower.
I find with small caps a large percentage of the time they go down due to impatience. Shareholders thought the company would grow quicker than it is. Still doesn't mean anything is wrong with this one imo